Optimization Peptides
Metabolic, hormonal, and longevity compounds for pre-clinical research.
Optimization peptides represent the frontier of metabolic and longevity science, covering GLP-1 receptor agonists, growth hormone secretagogues, NAD+ precursors, and mitochondrial peptides. This class has generated some of the most impactful clinical and pre-clinical research of the past decade, with compounds like Semaglutide demonstrating landmark results in weight management and cardiovascular risk studies.
For pre-clinical researchers, optimization peptides provide powerful tools to study insulin sensitivity, GH/IGF-1 axis dynamics, adipose tissue biology, mitochondrial biogenesis, and aging pathways. Compounds including Ipamorelin, Retatrutide, and MOTS-C are used across metabolic disease models, aging studies, and body composition research.
Research Applications & Benefits
GLP-1 & Metabolic Research
GLP-1, GIP, and glucagon receptor agonists are central to metabolic research, demonstrating significant effects on appetite regulation, insulin secretion, and adipose tissue lipolysis in published clinical and pre-clinical data.
Growth Hormone Axis Studies
Selective growth hormone secretagogues like Ipamorelin stimulate pulsatile GH release without cortisol confounding, enabling precise study of GH/IGF-1 axis dynamics, body composition, and bone density.
Longevity & Mitochondrial Biology
NAD+ precursors and mitochondrial-targeted peptides like MOTS-C have been studied for effects on sirtuin activation, mitochondrial biogenesis, and biomarkers of cellular aging across multiple model systems.
Body Composition Research
Optimization peptides are extensively used in lean mass preservation, adiposity reduction, and insulin sensitivity studies in aging, GH-deficient, and diet-induced obesity rodent models.
Common Research Use Cases
Optimization Peptides — Product Catalog
Frequently Asked Questions
Common questions from researchers working with optimization peptides.